{"id":"W1965148683","doi":"10.1016/j.ncl.2010.12.005","title":"Definitions of Breakthrough Disease and Second-Line Agents","year":2011,"lang":"en","type":"review","venue":"Neurologic Clinics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Medicine; Natalizumab; Observational study; Intensive care medicine; Disease; Mitoxantrone; Randomized controlled trial; Second line; Real world evidence; Clinical trial; First line; Surgery; Internal medicine; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003858605,0.002241911,0.00694086,0.01274366,0.0004323849,0.003225026,0.002228323,0.002517186,0.003196988],"category_scores_gemma":[0.0100916,0.0007584868,0.003295398,0.009572112,0.001990634,0.003681191,0.001790498,0.002841372,0.0005399614],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00253949,"about_ca_system_score_gemma":0.004248902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003342224,"about_ca_topic_score_gemma":0.007240478,"domain_scores_codex":[0.9971794,0.0006525948,0.001131261,0.0002901696,0.0006346991,0.0001118745],"domain_scores_gemma":[0.9914873,0.005189646,0.002422879,0.0001185867,0.0006566308,0.0001248895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004797814,0.00007679204,0.001015799,0.2595264,0.001766811,0.0002846444,0.0002775742,0.0005359397,0.0005023915,0.006577552,0.0220299,0.7069263],"study_design_scores_gemma":[0.0005699816,0.0004819427,0.006252628,0.2597535,0.008990703,0.004674898,0.0005658919,0.0006543203,0.000611169,0.005956702,0.7112996,0.0001887424],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000369687,0.9996164,0.00003478467,0.00009330732,0.00008421514,0.000004539578,0.00001229697,0.000001143634,0.0001162819],"genre_scores_gemma":[0.001084678,0.9980701,0.0002744691,0.0002549497,0.0001803636,0.00001603454,0.00003092342,9.4526e-7,0.00008755116],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01274366,"threshold_uncertainty_score":0.02040654,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5041909961136906,"score_gpt":0.4613418244338931,"score_spread":0.04284917167979746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}